Company Filing History:
Years Active: 2014-2019
Title: Nikunj Shukla: Innovator in Therapeutic Compounds
Introduction
Nikunj Shukla is a prominent inventor based in Lawrence, KS (US). He has made significant contributions to the field of therapeutic compounds, particularly in the area of Toll-like receptor agonists. With a total of 4 patents to his name, his work has the potential to impact various therapeutic applications.
Latest Patents
Shukla's latest patents focus on Toll-like receptor agonists, which are compounds that can be utilized for therapeutic purposes. These compounds can act as TLR agonists, specifically TLR7 or TLR8 agonists. They can be incorporated into pharmaceutical compositions and used in therapies where TLR agonism is beneficial. The pharmaceutical compositions may include various ingredients such as carriers, diluents, excipients, and fillers that are standard in the pharmaceutical industry. The compounds described can also include derivatives, prodrugs, salts, stereoisomers, tautomers, polymorphs, and solvates. Additionally, these compounds can serve as adjuvants in vaccines and for other therapeutic purposes.
Another significant aspect of his recent work involves novel imidazoquinoline derived compounds. This disclosure includes derivatives, analogues, and pharmaceutically acceptable salts, along with methods for their production and application. Shukla's research also encompasses TLR7 agonists and dual TLR7/TLR8 agonists, as well as self-adjuvanting vaccines that incorporate these compounds.
Career Highlights
Nikunj Shukla is affiliated with the University of Kansas Medical Center Research Institute. His work has been instrumental in advancing the understanding and application of TLR agonists in therapeutic settings. His innovative approach has garnered attention in the scientific community.
Collaborations
Shukla has collaborated with notable colleagues, including Sunil Abraham David and Euna Yoo. These partnerships have contributed to the development and refinement of his research in therapeutic compounds.
Conclusion
Nikunj Shukla's contributions to the field of therapeutic compounds, particularly through his patents on Toll-like receptor agonists, highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic applications and vaccine development.